etoposide has been researched along with Acrania in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avalos, B; Bechtel, T; Copelan, E; Elder, P; Ezzone, S; Farag, S; Hoshaw-Woodard, S; Lemeshow, S; Lin, T; Marcucci, G; Penza, S; Scholl, MD | 1 |
| Askin, FB; Bhatia, S; Burden, L; Chen, Z; Dickman, PS; Grier, HE; Krailo, MD; Link, MP; Meyers, PA; Miser, JS; Perlman, EJ; Rausen, AR; Robison, LL; Vietti, TJ | 1 |
| Bouchard, D; del Barco Barrantes, I; Duncan, GS; Elia, A; Mak, TW; Millar, DG; Nguyen, L; Ohashi, PS; Plyte, S; Ruland, J; Wakeham, A | 1 |
| Blume, KG; Brown, BW; Cao, TM; Hoppe, RT; Horning, S; Hu, WW; Johnston, LJ; Negrin, RS; Shizuru, JA; Stockerl-Goldstein, KE; Taylor, TL | 1 |
2 trial(s) available for etoposide and Acrania
| Article | Year |
|---|---|
Therapy-related myelodysplasia and leukemia occur infrequently following VP-16 priming and autotransplantation without total body irradiation.
Topics: Adolescent; Adult; Aged; Breast Neoplasms; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Incidence; Leukemia; Lymphoma; Male; Middle Aged; Neoplasms, Second Primary; Neural Tube Defects; Peripheral Blood Stem Cell Transplantation; Probability; Transplantation, Autologous | 2004 |
Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Incidence; Infant; Leukemia, Myeloid; Male; Neoplasms, Second Primary; Neural Tube Defects; Neuroectodermal Tumors, Primitive; Proportional Hazards Models; Risk; Sarcoma, Ewing; Vincristine | 2007 |
3 other study(ies) available for etoposide and Acrania
| Article | Year |
|---|---|
Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure.
Topics: Adaptor Proteins, Signal Transducing; Animals; Anisomycin; Antibody Formation; Antineoplastic Agents; Apoptosis; B-Cell CLL-Lymphoma 10 Protein; B-Lymphocytes; Cell Division; Central Nervous System; Cisplatin; Enzyme Inhibitors; Etoposide; Genes, Lethal; Immunity, Cellular; Lymphocyte Activation; Mice; Mice, Knockout; Neoplasm Proteins; Neural Tube Defects; NF-kappa B; Nucleic Acid Synthesis Inhibitors; Protein Synthesis Inhibitors; Receptors, Antigen; Signal Transduction; Staurosporine; T-Lymphocytes | 2001 |
High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: the Stanford University experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Follicular; Male; Middle Aged; Neural Tube Defects; Prognosis; Recurrence; Remission Induction; Retrospective Studies; Survival Analysis; Transplantation, Autologous; Treatment Outcome; Whole-Body Irradiation | 2001 |
Secondary pre-leukaemia and etoposide.
Topics: Etoposide; Humans; Leukemia, Myeloid, Acute; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Neural Tube Defects | 1991 |